Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma.
Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma. Semin Oncol. 1995 Feb; 22(1):67-73.
View in:
PubMed
subject areas
Animals
Carcinoma, Renal Cell
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Combined Modality Therapy
Drug Administration Schedule
Humans
Interferon-alpha
Interleukin-2
Kidney Neoplasms
authors with profiles
Walter M. Stadler